SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000947871-19-000690
Filing Date
2019-09-18
Accepted
2019-09-18 16:16:49
Documents
2
Group Members
ORBIMED CAPITAL GP VII LLCORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss150673_sc13d.htm SC 13D 100119
2 JOINT FILING AGREEMENT ss150673_ex9901.htm EX-99.1 6077
  Complete submission text file 0000947871-19-000690.txt   107814
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 450-680-4500
BELLUS Health Inc. (Subject) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79463 | Film No.: 191099925
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences